Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Citi
Accenture
Express Scripts
Moodys
Chubb

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 9,987,356

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,987,356
Title:Anti-CD40 antibodies and methods of administering thereof
Abstract: The present invention relates to antibodies specific for a particular epitope on CD40 and antibodies that bind CD40 and have particular functional characteristics. The present invention also relates to fragments of these antibodies, uses of the antibodies for reduction or treatment of transplant rejection and graft-versus-host disease, and methods for making the antibodies.
Inventor(s): Reimann; Keith A. (Marblehead, MA), Wang; Rijian (Saugus, MA), Larsen; Christian P. (Atlanta, GA)
Assignee: Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA)
Application Number:14/004,552
Patent Claims:see list of patent claims

Details for Patent 9,987,356

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) ➤ Sign Up RX search
Bristol Myers Squibb NULOJIX belatacept INJECTABLE; INJECTION 125288 001 2011-06-15 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) ➤ Sign Up RX search
Genzyme LEMTRADA alemtuzumab INJECTABLE;INJECTION 103948 003 2001-05-07 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) ➤ Sign Up RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 002 2001-05-07 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) ➤ Sign Up RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 001 2001-05-07 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) ➤ Sign Up RX Orphan search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Mallinckrodt
Cipla
Farmers Insurance
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.